within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWithCorticosteroids.G01AA02_Natamycin;

model Natamycin
  extends Pharmacolibrary.Drugs.ATC.G.G01AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G01AA02</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Natamycin is a polyene antifungal medication used primarily for the treatment of fungal infections of the eye (such as conjunctivitis, keratitis, and blepharitis). It is approved for topical ophthalmic use and is not systemically absorbed in significant amounts. Natamycin is also used as a food preservative due to its antifungal properties.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for topical ophthalmic administration in healthy adults. Due to its extremely low solubility and poor penetration, natamycin is characterized by negligible systemic absorption.</p><h4>References</h4><ol><li><p>Zhao, X, et al., &amp; Lu, H (2018). Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(6) 460–467. DOI:<a href=&quot;https://doi.org/10.1089/jop.2017.0139&quot;>10.1089/jop.2017.0139</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29792548/&quot;>https://pubmed.ncbi.nlm.nih.gov/29792548</a></p></li><li><p>Bhatta, RS, et al., &amp; Shukla, PK (2012). Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies. <i>International journal of pharmaceutics</i> 432(1-2) 105–112. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2012.04.060&quot;>10.1016/j.ijpharm.2012.04.060</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22569234/&quot;>https://pubmed.ncbi.nlm.nih.gov/22569234</a></p></li><li><p>Velpandian, T, et al., &amp; Halder, N (2021). Novel water soluble sterile natamycin formulation (Natasol) for fungal keratitis. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 163 105857–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2021.105857&quot;>10.1016/j.ejps.2021.105857</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33882328/&quot;>https://pubmed.ncbi.nlm.nih.gov/33882328</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Natamycin;
